Quantcast

Latest Umbilical cord Stories

2014-10-24 23:03:52

Americord launches revolutionary process, Cord Blood 2.0™ to preserve up to twice as many stem cells in umbilical cord blood. New York, NY (PRWEB) October 24, 2014 Americord Registry announced today the launch of Cord Blood 2.0™, its innovative cord blood banking system that can collect and preserve up to twice as many stem cells as traditional cord blood collections. “Traditional cord blood banking is outdated,” said Americord CEO Martin Smithmyer. “Cord Blood 2.0™ for cord...

2014-10-14 08:34:02

SACRAMENTO, Calif., Oct. 14, 2014 /PRNewswire/ -- SynGen, Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has moved its corporate headquarters to a new location in Sacramento, California. The headquarter's new address is 100 Howe Avenue, Suite 185N, Sacramento, CA 95825-8219. All other contact information,...

2014-10-05 08:21:00

SACRAMENTO, Calif., Oct. 5, 2014 /PRNewswire/ -- SynGen, Inc., a company that focuses on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that it has secured additional financing from Bay City Capital, LLC, a San Francisco-based life sciences venture capital firm. http://photos.prnewswire.com/prnvar/20141002/150061 Bay City Capital invested...

2014-10-03 08:24:33

LAS VEGAS, Oct. 3, 2014 /PRNewswire/ -- Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company") today announced that it has sold its 50.004% ownership stake in Argentina based Biocordcell Argentina, S.A. (Bio) to Diego Rissola, current President and shareholder in Bio, for approximately $705,000, to be paid with three payments due by March 2015, and then annual payments from June 2015 through June 2025. The shares purchased pursuant to...

2014-09-30 12:29:55

ORLANDO, Fla., Sept. 30, 2014 /PRNewswire/ -- CORD:USE Cord Blood Bank - www.corduse.com - is pleased to announce that it has entered into an Equity and Exclusive Services Agreement with Tianhe Stem Cell Biotechnologies, Inc. (Tianhe) which has licensed a series of patented technologies for the isolation of human cord blood-derived multipotent stem cells for possible clinical applications. Tianhe is performing Phase I/II clinical trials in China and Spain using Tianhe's Stem Cell...

2014-09-26 08:25:03

HONG KONG, Sept. 26, 2014 /PRNewswire/ --China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 2014 annual general meeting of shareholders at its Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. Hong Kong Time on December 11, 2014 (8:00 a.m....

2014-09-22 08:29:37

Research explores the benefits of using autologous cord blood stem cells for children with Cerebral Palsy NEW YORK, Sept. 22, 2014 /PRNewswire/ -- Americord announced today that it has provided funding to support a clinical trial investigating the efficacy of autologous umbilical cord blood for the treatment of pediatric patients with cerebral palsy. Logo - http://photos.prnewswire.com/prnh/20140919/147316 This trial is being conducted under the direction of an internationally...

2014-09-10 16:26:28

SAN BRUNO, Calif., Sept. 10, 2014 /PRNewswire/ -- September is designated as National Childhood Cancer Awareness Month. The federal health observance provides an opportunity to heighten awareness of the formidable public health challenges presented by childhood cancer. According to the National Cancer Institute, cancer is the leading cause of death by disease in children and adolescents ages 1 to 19 years old in the United States. Pediatric patients with blood cancers have diseased...

2014-09-05 08:23:18

HONG KONG, Sept. 5, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company's Compensation Committee (the "Committee") has approved an allocation of 5,840,000 restricted share units ("RSUs") to be issued to selected members (the "Potential Participants") of the CCBC management team....

2014-08-25 08:27:08

HONG KONG, Aug. 25, 2014 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company has been informed that Magnum Opus International Holdings Limited ("Magnum"), a private vehicle that is controlled by CCBC Chairman Mr. Yuen KAM and involves the CCBC management team, together with Cordlife...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related